indeloxazine has been researched along with Amentia in 5 studies
indeloxazine: RN given refers to parent cpd without isomeric designation
| Excerpt | Relevance | Reference |
|---|---|---|
| " Plasma concentrations of cerebral metabolic activating drugs (bifemelane, indeloxazine and propentofylline) were studied in 68 patients (male 25, female 43) with dementia or other organic brain diseases." | 3.69 | A preliminary study on plasma concentrations of bifemelane, indeloxazine and propentofylline in aged patients with organic brain disorders. ( Arai, H; Inoue, R; Kimura, M; Minami, M; Noguchi, I; Suzuki, T; Takahashi, T, 1995) |
| "Event-related potentials, measured eight times in a patient in the early stages of dementia, demonstrated that clinical symptoms, especially loss of motivation, improved coincidentally with a shortening of reaction time, N1 latency, and P3 latency during nicergoline medication among three nootropics prescribed." | 3.68 | Shortening of N1 and P3 latencies in event-related potentials observed coincidentally with clinical improvement during nootropic medication in a demented patient: specific effect of nicergoline. ( Fukuda, M; Hata, A; Hayashida, S; Hiramatsu, K; Honda, H; Honda, M; Iwanami, A; Nakagome, K; Niwa, S; Sasaki, T, 1992) |
| "Effects of indeloxazine, a new compound which has been though to block reuptake of serotonin and noradrenaline, on cerebrospinal fluid monoamine metabolites were evaluated in 11 patients with dementia." | 3.67 | Effects of indeloxazine, (+)-2-[inden-7-yloxy)methyl]morpholine hydrochloride on cerebrospinal fluid monoamine metabolites. ( Fukuzawa, N; Mizuno, Y; Shimabukuro, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minami, M | 1 |
| Arai, H | 1 |
| Takahashi, T | 2 |
| Kimura, M | 1 |
| Noguchi, I | 1 |
| Suzuki, T | 1 |
| Inoue, R | 1 |
| Otomo, E | 1 |
| Fukuda, M | 1 |
| Hiramatsu, K | 1 |
| Honda, M | 1 |
| Niwa, S | 1 |
| Sasaki, T | 1 |
| Hata, A | 1 |
| Nakagome, K | 1 |
| Iwanami, A | 1 |
| Honda, H | 1 |
| Hayashida, S | 1 |
| Kataoka, K | 1 |
| Mizuno, Y | 1 |
| Shimabukuro, T | 1 |
| Fukuzawa, N | 1 |
1 review available for indeloxazine and Amentia
| Article | Year |
|---|---|
[Cerebral circulatory improvers and metabolic activators].
Topics: Aged; Antidepressive Agents; Benzoquinones; Brain; Cerebrovascular Circulation; Cerebrovascular Diso | 1994 |
4 other studies available for indeloxazine and Amentia
| Article | Year |
|---|---|
A preliminary study on plasma concentrations of bifemelane, indeloxazine and propentofylline in aged patients with organic brain disorders.
Topics: Aged; Antidepressive Agents; Benzhydryl Compounds; Dementia; Female; Humans; Male; Morpholines; Xant | 1995 |
Shortening of N1 and P3 latencies in event-related potentials observed coincidentally with clinical improvement during nootropic medication in a demented patient: specific effect of nicergoline.
Topics: Aged; Benzhydryl Compounds; Dementia; Electroencephalography; Evoked Potentials; Humans; Male; Morph | 1992 |
Influence of indeloxazine hydrochloride upon photic driving responses elicited by flickering dot pattern and red flicker stimuli in elderly patients.
Topics: Aged; Antidepressive Agents; Arousal; Cerebral Cortex; Color Perception; Dementia; Electroencephalog | 1990 |
Effects of indeloxazine, (+)-2-[inden-7-yloxy)methyl]morpholine hydrochloride on cerebrospinal fluid monoamine metabolites.
Topics: Adult; Aged; Aged, 80 and over; Dementia; Dopamine; Female; Glycols; Homovanillic Acid; Humans; Hydr | 1988 |